This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Sericultural &Agri-Food Research Institute Guangdong Academy of Agricultural Sciences. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Mingwei Zhang in Triterpenoid Research
Introduction
Mingwei Zhang is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of natural medicines, particularly in the area of glucose and lipid metabolism disorders. His innovative work has the potential to impact diabetes treatment positively.
Latest Patents
Mingwei Zhang holds a patent for the "Preparation and application of triterpenoids with effect of improving glucose and lipid metabolism disorders." This invention relates to a novel triterpenoid compound obtained from L. for the first time. The compound has shown promising results in regulating glucose and lipid metabolism, especially when combined with the known triterpenoid compound Momordicoside G. This combination demonstrates enhanced activity compared to the individual compounds, indicating a new approach to treating metabolic disorders.
Career Highlights
Mingwei Zhang is affiliated with the Sericultural and Agri-Food Research Institute at the Guangdong Academy of Agricultural Sciences. His research focuses on the development of natural compounds that can aid in the management of metabolic disorders. With 1 patent to his name, he is recognized for his innovative contributions to the field.
Collaborations
Mingwei Zhang has collaborated with notable colleagues, including Yuanyuan Deng and Guang Liu. Their combined efforts in research have further advanced the understanding of triterpenoid compounds and their applications in medicine.
Conclusion
Mingwei Zhang's work in the field of natural medicines, particularly with triterpenoids, showcases his innovative spirit and dedication to improving health outcomes. His research holds promise for new treatments in managing glucose and lipid metabolism disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile